| pubmed-article:8996526 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C0597710 | lld:lifeskim |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C0058126 | lld:lifeskim |
| pubmed-article:8996526 | lifeskim:mentions | umls-concept:C1947916 | lld:lifeskim |
| pubmed-article:8996526 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8996526 | pubmed:dateCreated | 1997-2-6 | lld:pubmed |
| pubmed-article:8996526 | pubmed:abstractText | The pharmacokinetics of 5-fluorouracil (5-FU) in different animal species treated with the dihydropyrimidine dehydrogenase (DPD) inactivator, 5-ethynyluracil (776C85) were related through allometric scaling. Estimates of 5-FU dose in combination with 776C85 were determined from pharmacokinetic and toxicodynamic analysis. | lld:pubmed |
| pubmed-article:8996526 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8996526 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8996526 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8996526 | pubmed:issn | 0344-5704 | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:BaccanariD... | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:NelsonDD | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:SpectorTT | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:KeilR LRL | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:DavisS TST | lld:pubmed |
| pubmed-article:8996526 | pubmed:author | pubmed-author:AmyxHH | lld:pubmed |
| pubmed-article:8996526 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8996526 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:8996526 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8996526 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8996526 | pubmed:pagination | 233-8 | lld:pubmed |
| pubmed-article:8996526 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:meshHeading | pubmed-meshheading:8996526-... | lld:pubmed |
| pubmed-article:8996526 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:8996526 | pubmed:articleTitle | Dihydropyrimidine dehydrogenase inactivation and 5-fluorouracil pharmacokinetics: allometric scaling of animal data, pharmacokinetics and toxicodynamics of 5-fluorouracil in humans. | lld:pubmed |
| pubmed-article:8996526 | pubmed:affiliation | Glaxo Wellcome Inc., Research Triangle Park, NC 27709, USA. | lld:pubmed |
| pubmed-article:8996526 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8996526 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8996526 | lld:pubmed |
